Global Pricing & Value Strategist

Pauwels Consulting; Eigenbrakel; Sur place; EUR 90 000 - 130 000; Plein temps

Résumé du poste

Pauwels Consulting is seeking a strategic pricing leader to drive pricing strategy for early-stage candidates and pipeline solutions in a global pharmaceutical setting. You will translate payer requirements into actionable pricing strategies and forecast inputs to support key development decisions.

The role involves developing price assumptions, evidence plans, and launch sequencing while monitoring HTA trends and funding dynamics to identify risks and opportunities for the portfolio.

Qualifications

• Bachelor’s degree in life sciences, economics, business, pharmacy, or related discipline.

Responsabilités

• Translate payer requirements and competitive dynamics into actionable pricing strategies and long-range forecast inputs.
• Develop target gross and net price assumptions, potential price corridors, and launch sequencing scenarios.
• Identify the clinical, economic, and real-world evidence required to substantiate value propositions and reimbursement ambitions.
• Monitor evolving pricing, HTA, and funding trends to identify risks and opportunities for the portfolio.
• Deliver documented and audit-ready pricing inputs for business cases, portfolio decisions, and due diligence processes.
• Facilitate strategic alignment across global functions and regional markets to ensure consistency in pricing deliverables.
• Manage external vendor engagements and research projects to ensure analytical quality and adherence to budgets.

Connaissances

Pricing strategy

HTA knowledge

Vendor management

Stakeholder alignment

Analytical skills

English fluency

Problem solving

Formation

Bachelor’s degree in life sciences/economics/business/pharmacy

Description du poste

Pauwels Consulting is seeking a strategic pricing leader to drive pricing strategy for early-stage candidates and pipeline solutions in a global pharmaceutical setting. You will translate payer requirements into actionable pricing strategies and forecast inputs to support key development decisions.

The role involves developing price assumptions, evidence plans, and launch sequencing while monitoring HTA trends and funding dynamics to identify risks and opportunities for the portfolio.